Plasma folate, methylenetetrahydrofolate reductase (MTHFR), and colorectal cancer risk in three large nested case-control studies

Cancer Causes and Control

Volumn 23, Issue 4, 2012, Pages 537-545

  Lee, Jung Eun ^a   Wei, Esther K ^b,c   Fuchs, Charles S ^c,d   Hunter, David J ^c,e   Lee, I Min ^c,e   Selhub, Jacob ^f   Stampfer, Meir J ^c,e   Willett, Walter C ^c,e   Ma, Jing ^c   Giovannucci, Edward ^c,e  

^a Sookmyung Women's University   (South Korea)

^b CALIFORNIA PACIFIC MEDICAL CENTER   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d DANA FARBER CANCER INSTITUTE   (United States)

^e HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^f TUFTS UNIVERSITY   (United States)

Author keywords

Colorectal cancer; Folate; Methylenetetrahydrofolate reductase (MTHFR)

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); ACETYLSALICYLIC ACID; ADENINE; CALCIUM; CYTOSINE; FOLIC ACID; MULTIVITAMIN; THYMINE;

ADULT; AGED; ALCOHOL CONSUMPTION; ARTICLE; BLOOD ANALYSIS; BODY HEIGHT; BODY WEIGHT; CANCER RISK; CASE CONTROL STUDY; CIGARETTE SMOKING; COLORECTAL CANCER; CONFIDENCE INTERVAL; CONTROLLED STUDY; DAIRY PRODUCT; DISEASE ASSOCIATION; FAMILY HISTORY; FEMALE; FOLIC ACID BLOOD LEVEL; FOOD INTAKE; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; PHYSICAL ACTIVITY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RED MEAT; RISK ASSESSMENT;

ADULT; AGED; CASE-CONTROL STUDIES; COLORECTAL NEOPLASMS; FEMALE; FOLIC ACID; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS;

EID: 84862810403     PISSN: 09575243     EISSN: 15737225     Source Type: Journal    
DOI: 10.1007/s10552-012-9911-3     Document Type: Article

References (34)

1. Choi SW, Mason JB (2002) Folate status: effects on pathways of colorectal carcinogenesis. J Nutr 132:2413S-2418S
2. Lamprecht SA, Lipkin M (2003) Chemoprevention of colon cancer by calcium, vitamin D and folate: molecular mechanisms. Nat Rev Cancer 3:601-614 (Pubitemid 37328832)
3. Slattery ML, Potter JD, Samowitz W, Schaffer D, Leppert M (1999) Methylenetetrahydrofolate reductase, diet, and risk of colon cancer. Cancer Epidemiol Biomarkers Prev 8:513-518 (Pubitemid 29270335)
4. Giovannucci E, Stampfer MJ, Colditz GA et al (1993) Folate, methionine, and alcohol intake and risk of colorectal adenoma. J Natl Cancer Inst 85:875-884 (Pubitemid 23157127)
5. Kato I, Dnistrian AM, Schwartz M et al (1999) Serum folate, homocysteine and colorectal cancer risk in women: a nested case-control study. Br J Cancer 79:1917-1922 (Pubitemid 29132325)
6. Glynn SA, Albanes D, Pietinen P et al (1996) Colorectal cancer and folate status: a nested case-control study among male smokers. Cancer Epidemiol Biomarkers Prev 5:487-494 (Pubitemid 26235013)
7. Van Guelpen B, Hultdin J, Johansson I, et al. (2006) Low folate levels may protect against colorectal cancer. Gut 55:1461-1466
8. Otani T, Iwasaki M, Sasazuki S, Inoue M, Tsugane S (2008) Plasma folate and risk of colorectal cancer in a nested case-control study: the Japan public health center-based prospective study. Cancer Causes Control 19:67-74
9. Le Marchand L, White KK, Nomura AM et al (2009) Plasma levels of B vitamins and colorectal cancer risk: the multiethnic cohort study. Cancer Epidemiol Biomarkers Prev 18:2195-2201
10. Eussen SJ, Vollset SE, Igland J et al (2010) Plasma folate, related genetic variants, and colorectal cancer risk in EPIC. Cancer Epidemiol Biomarkers Prev 19:1328-1340
11. Weinstein SJ, Albanes D, Selhub J et al (2008) One-carbon metabolism biomarkers and risk of colon and rectal cancers. Cancer Epidemiol Biomarkers Prev 17:3233-3240
12. Cole BF, Baron JA, Sandler RS et al (2007) Folic acid for the prevention of colorectal adenomas: a randomized clinical trial. JAMA 297:2351-2359 (Pubitemid 46883748)
13. Logan RF, Grainge MJ, Shepherd VC, Armitage NC, Muir KR (2008) Aspirin and folic acid for the prevention of recurrent colorectal adenomas. Gastroenterology 134:29-38 (Pubitemid 350309319)
14. Wu K, Platz EA, Willett WC et al (2009) A randomized trial on folic acid supplementation and risk of recurrent colorectal adenoma. Am J Clin Nutr 90:1623-1631
15. Frosst P, Blom HJ, Milos R et al (1995) A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet 10:111-113
16. van der Put NM, Gabreels F, Stevens EM et al (1998) A second common mutation in the methylenetetrahydrofolate reductase gene: an additional risk factor for neural-tube defects? Am J Hum Genet 62:1044-1051 (Pubitemid 28199004)
17. Hubner RA, Houlston RS (2007) MTHFR C677T and colorectal cancer risk: a meta-analysis of 25 populations. Int J Cancer 120:1027-1035 (Pubitemid 46214302)
18. Ma J, Stampfer MJ, Giovannucci E et al (1997) Methylenetetrahydrofolate reductase polymorphism, dietary interactions, and risk of colorectal cancer. Cancer Res 57:1098-1102 (Pubitemid 27138608)
19. Tamura T, Freeberg LE, Cornwell PE (1990) Inhibition of EDTA of growth of Lactobacillus casei in the folate microbiological assay and its reversal by added manganese or iron. Clin Chem 36:1993
20. Laird NM, Ware JH (1982) Random-effects models for longitudinal data. Biometrics 38:963-974
21. DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Controll Clin Trials 7:177-188 (Pubitemid 17189972)
22. Stram DO (1996) Meta-analysis of published data using a linear mixed-effects model. Biometrics 52:536-544
23. Chen J, Giovannucci E, Kelsey K et al (1996) A methylenetetrahydrofolate reductase polymorphism and the risk of colorectal cancer. Cancer Res 56:4862-4864 (Pubitemid 26374419)
24. Kono S, Chen K (2005) Genetic polymorphisms of methylenetetrahydrofolate reductase and colorectal cancer and adenoma. Cancer Sci 96:535-542 (Pubitemid 41488416)
25. Bagley PJ, Selhub J (1998) A common mutation in the methylenetetrahydrofolate reductase gene is associated with an accumulation of formylated tetrahydrofolates in red blood cells. Proc Natl Acad Sci USA 95:13217-13220 (Pubitemid 28509551)
26. Friso S, Choi SW, Girelli D et al (2002) A common mutation in the 5,10-methylenetetrahydrofolate reductase gene affects genomic DNA methylation through an interaction with folate status. Proc Natl Acad Sci USA 99:5606-5611 (Pubitemid 34411596)
27. Song J, Medline A, Mason JB, Gallinger S, Kim YI (2000) Effects of dietary folate on intestinal tumorigenesis in the apcMin mouse. Cancer Res 60:5434-5440
28. Song J, Sohn KJ, Medline A, Ash C, Gallinger S, Kim YI (2000) Chemopreventive effects of dietary folate on intestinal polyps in Apc ± Msh2-/- mice. Cancer Res 60:3191-3199 (Pubitemid 30407916)
29. Lee JE, Willett WC, Fuchs CS et al (2011) Folate intake and the risk of colorectal cancer and adenoma: modification by time. Am J Clin Nutr 93:817-825
30. Troen AM, Mitchell B, Sorensen B et al (2006) Unmetabolized folic acid in plasma is associated with reduced natural killer cell cytotoxicity among postmenopausal women. J Nutr 136:189-194 (Pubitemid 43156507)
31. Sweeney MR, McPartlin J, Scott J (2007) Folic acid fortification and public health: report on threshold doses above which unmetabolised folic acid appear in serum. BMC Public Health 7:41
32. Martinez ME, Giovannucci E, Jiang R, et al. (2006) Folate fortification, plasma folate, homocysteine and colorectal adenoma recurrence. Int J Cancer 119:1440-1446 (Pubitemid 44258823)
33. Rock CL (2007) Multivitamin-multimineral supplements: who uses them? Am J Clin Nutr 85:277S-279S
34. Dietrich M, Brown CJ, Block G (2005) The effect of folate fortification of cereal-grain products on blood folate status, dietary folate intake, and dietary folate sources among adult non-supplement users in the United States. J Am Coll Nutr 24:266-274 (Pubitemid 43193852)